Picture of Redsense Medical AB (publ) logo

REDS Redsense Medical AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Redsense Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-9.03-7.97-8.76-4.510.342
Non-Cash Items1.68-2.12-0.03-1.52-1.02
Other Non-Cash Items
Changes in Working Capital3.51-2.13-0.9950.979-7.55
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-3.84-12.2-9.78-5.05-8.23
Capital Expenditures-2.81-0.36-0.048-0.052-0.611
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-39-9.3510.98.40
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities-41.9-9.7110.98.35-0.611
Financing Cash Flow Items-5.310.001
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities66.2-1.89-2.4017.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash20.3-24-1.313.298.39